Frailty-stratified randomised controlled bayesian adaptive trial of bortezomib versus lenalidomide in transplant-ineligible myeloma - the FRAIL-M study

Project Member(s): De Abreu Lourenco, R.

Funding or Partner Organisation: Medical Research Future Fund (Medical Research Future Fund - Low Survival Cancers Rare Diseases and Unmet Need)
Medical Research Future Fund (Medical Research Future Fund - Low Survival Cancers Rare Diseases and Unmet Need)

Start year: 2019

FOR Codes: Health economics , Cancer and Related Disorders, Health Policy Economic Outcomes, Health Economics, Clinical health, Evaluation of health and support services

Acknowledgement of Country

UTS acknowledges the Gadigal people of the Eora Nation, the Boorooberongal people of the Dharug Nation, the Bidiagal people and the Gamaygal people, upon whose ancestral lands our university stands. We would also like to pay respect to the Elders both past and present, acknowledging them as the traditional custodians of knowledge for these lands.